DON'T BUY
A leader in its sector. If the sector turned up, it would be good.
DON'T BUY
Not a fan of pharmaceuticals and this one is not the best.
DON'T BUY
Wait for the sector to start to strengthen.
BUY
Should be in production in February or March.
DON'T BUY
Too many problems.
DON'T BUY
A lot of competition. Can't seem to make money.
DON'T BUY
Governments are trying to cut health care costs. Sector seems to be weak.
HOLD
Sector is starting to firm up a little.
DON'T BUY
Metal sector is weakening.
DON'T BUY
Still more problems to come. There are some balance sheet concerns.
DON'T BUY
Too much weakness in the economy. Not cheap.
WAIT
Watching it.
BUY
Has performed well. Has a lot of upcoming developments.
DON'T BUY
Very thin profit margins. No sign that things are getting better.
DON'T BUY
US banks continue to have problems. Also, the dividend is at risk.